Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
Peter A. Ringleb, Marie Germaine Bousser, Gary A. Ford, et al.
Cerebrovascular Diseases (2008) Vol. 25, Iss. 5, pp. 457-507
Open Access | Times Cited: 2450

Showing 1-25 of 2450 citing articles:

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Qinghua Zhang, Chao Wang, Maoyong Zheng, et al.
Cerebrovascular Diseases (2014) Vol. 39, Iss. 1, pp. 13-22
Open Access | Times Cited: 11420
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
Edward C. Jauch, Jeffrey L. Saver, Harold P. Adams, et al.
Stroke (2013) Vol. 44, Iss. 3, pp. 870-947
Open Access | Times Cited: 7446
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Werner Hacke, Markku Kaste, Erich Bluhmki, et al.
New England Journal of Medicine (2008) Vol. 359, Iss. 13, pp. 1317-1329
Open Access | Times Cited: 6160
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers, Alejandro A. Rabinstein, Teri Ackerson, et al.
Stroke (2019) Vol. 50, Iss. 12
Closed Access | Times Cited: 5389
Endovascular Stroke Therapy Results Improve over Time: The ‘Learning Curve' at a New Comprehensive Stoke Center
Ethan A. Benardete, Anil K. Nair
Cerebrovascular Diseases Extra (2015) Vol. 4, Iss. 3, pp. 235-242
Open Access | Times Cited: 2541
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson, Kennedy R. Lees, Patrick D. Lyden, et al.
The Lancet (2014) Vol. 384, Iss. 9958, pp. 1929-1935
Open Access | Times Cited: 2306
Stroke rehabilitation
Peter Langhorne, Julie Bernhardt, Gert Kwakkel
The Lancet (2011) Vol. 377, Iss. 9778, pp. 1693-1702
Closed Access | Times Cited: 2182
Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care

OECD health policy studies (2015)
Closed Access | Times Cited: 1594
Embolic strokes of undetermined source: the case for a new clinical construct
Robert G. Hart, Hans‐Christoph Diener, Shelagh B. Coutts, et al.
The Lancet Neurology (2014) Vol. 13, Iss. 4, pp. 429-438
Closed Access | Times Cited: 1480
Thrombolysis for acute ischaemic stroke
Joanna M. Wardlaw, Veronica Murray, Eivind Berge, et al.
Cochrane library (2014) Vol. 2016, Iss. 1
Open Access | Times Cited: 1335
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
Götz Thomalla, Claus Z. Simonsen, Florent Boutitie, et al.
New England Journal of Medicine (2018) Vol. 379, Iss. 7, pp. 611-622
Open Access | Times Cited: 1092
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Jean‐Louis Mas, Geneviève Dérumeaux, B. Guillon, et al.
New England Journal of Medicine (2017) Vol. 377, Iss. 11, pp. 1011-1021
Open Access | Times Cited: 1018
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
Lars Søndergaard, Scott E. Kasner, John F. Rhodes, et al.
New England Journal of Medicine (2017) Vol. 377, Iss. 11, pp. 1033-1042
Open Access | Times Cited: 978
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
Ralph L. Sacco, Hans‐Christoph Diener, Salim Yusuf, et al.
New England Journal of Medicine (2008) Vol. 359, Iss. 12, pp. 1238-1251
Open Access | Times Cited: 946
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Eivind Berge, William Whiteley, Heinrich J. Audebert, et al.
European Stroke Journal (2021) Vol. 6, Iss. 1, pp. I-LXII
Open Access | Times Cited: 854
Cervical-artery dissections: predisposing factors, diagnosis, and outcome
Stéphanie Debette, Didier Leys
The Lancet Neurology (2009) Vol. 8, Iss. 7, pp. 668-678
Closed Access | Times Cited: 737
Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis
Luciano A. Sposato, Lauren E. Cipriano, Gustavo Saposnik, et al.
The Lancet Neurology (2015) Vol. 14, Iss. 4, pp. 377-387
Closed Access | Times Cited: 638
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
Pierre Amarenco, Julien Labreuche
The Lancet Neurology (2009) Vol. 8, Iss. 5, pp. 453-463
Closed Access | Times Cited: 633
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke
Bart M. Demaerschalk, Dawn Kleindorfer, Opeolu Adeoye, et al.
Stroke (2015) Vol. 47, Iss. 2, pp. 581-641
Closed Access | Times Cited: 600
Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study
Nils Wahlgren, Niaz Ahmed, Antoni Dávalos, et al.
The Lancet (2008) Vol. 372, Iss. 9646, pp. 1303-1309
Closed Access | Times Cited: 573
Mass Screening for Untreated Atrial Fibrillation
Emma Svennberg, Johan Engdahl, Faris Al‐Khalili, et al.
Circulation (2015) Vol. 131, Iss. 25, pp. 2176-2184
Closed Access | Times Cited: 544
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study
Götz Thomalla, Bastian Cheng, Martin Ebinger, et al.
The Lancet Neurology (2011) Vol. 10, Iss. 11, pp. 978-986
Closed Access | Times Cited: 543
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Else Charlotte Sandset, Philip M. Bath, Gudrun Boysen, et al.
The Lancet (2011) Vol. 377, Iss. 9767, pp. 741-750
Closed Access | Times Cited: 523
Basilar artery occlusion
Heinrich P. Mattle, Marcel Arnold, Perttu J. Lindsberg, et al.
The Lancet Neurology (2011) Vol. 10, Iss. 11, pp. 1002-1014
Closed Access | Times Cited: 505
The complexity of neurobiological processes in acute ischemic stroke
Raf Brouns, Peter Paul De Deyn
Clinical Neurology and Neurosurgery (2009) Vol. 111, Iss. 6, pp. 483-495
Closed Access | Times Cited: 504
Page 1 - Next Page

Scroll to top